Table 1 Overview of the patient data related to treatment indication and fractionation. The physics dose limitations for the most common OARs are included together with the delivery technique clinically used in our center
From: Initial characterization, dosimetric benchmark and performance validation of Dynamic Wave Arc
Site | Nr. of patients | Fractionation | Minimum % of PD covering PTV | PTV Volume (ccm) | OAR | Dose constrains | Clinical delivery technique | |
|---|---|---|---|---|---|---|---|---|
Prostate | 3 |  | 78Gy(2Gy/fx) | >90 % | 171.8 [129.8-222.8] | Rectum | D2% < 74.1 Gy V70.2Gy < 25 % V62.4Gy < 50 % | 5 IMRT beams |
Oligo-metastatic cases | 9 | 5 x1lesion 2x2lesions 2x3lesions | 50Gya(5Gy/fx) | 100 % | 28.0 [12.2-57.5] | Lung Liver | V20Gy < 25 % V30Gy < 30 % Dmean < 22 Gy | 8-10 CRT beams per lesion |
Centrally-located NSCLC | 9 | 6 lesions 3 lesions | 48Gyb(12Gy/fx) 60Gy(7.5Gy/fx) | >95 % >95 % | 76.2 [17.2-209.7] | Esophagus Spinal cord Heart Proximal- bronchus Lung | D2% < 30 Gy D2% < 26 Gy D2% < 34 Gy D2% < 34 Gy V20Gy < (8-10)% | 8-10 CRT beams |
LAPC | 10 |  | 48Gy(3.2Gy/fx) | >95 % | 188.5 [140.6-257.2] | Duodenum | V39Gy < 1.0 cc V36Gy < 10 cc | 6 IMRT beams |
Stomach Kidney Liver | V39Gy < 1.0 cc V36Gy < 10 cc V20Gy < 30 % Dmean < 30 Gy | |||||||